Millennium Management’s Cocrystal Pharma COCP Stock Holding History

Millennium Management’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-880	Closed	-$3K	–	6622
2022 Q3	$3K	Buy	+880	New	+$4.12K	﹤0.01%	6876
2021 Q4	–	Sell	-11,353	Closed	-$143K	–	6869
2021 Q3	$143K	Buy	+11,353	New	+$150K	﹤0.01%	6267
2021 Q1	–	Sell	-1,792	Closed	-$29K	–	5993
2020 Q4	$29K	Buy	+1,792	New	+$24.9K	﹤0.01%	5116
2019 Q4	–	Sell	-1,099	Closed	-$26K	–	4261
2019 Q3	$26K	Buy	+1,099	New	+$28.5K	﹤0.01%	4080
2018 Q4	–	Sell	-26,821	Closed	-$805K	–	3797
2018 Q3	$805K	Sell	26,821 -7,370	-22%	-$330K	﹤0.01%	2985
2018 Q2	$1.5M	Buy	+34,191	New	+$1.27M	﹤0.01%	2595

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's COCP Position: Q4 2022 in Review

Millennium Management sold out of Cocrystal Pharma (COCP) in Q4 2022, closing a stake of 880 shares — an estimated $3K sold.

Millennium Management first reported a position in COCP in Q2 2018 and held it in 6 quarters. The position peaked at $1.5M in Q2 2018. 21 funds tracked by Wall St. Rank hold COCP as of Q4 2022.

Millennium Management reported no remaining Cocrystal Pharma position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 880 Cocrystal Pharma shares in Q4 2022, an estimated $3K.
Millennium Management first reported a position in Cocrystal Pharma in Q2 2018 and held it in 6 quarters.
Millennium Management's Cocrystal Pharma position peaked at $1.5M in Q2 2018.
21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.